The Effects of Androgens on Murine Cortical Bone Do Not Require AR or ERα Signaling in Osteoblasts and Osteoclasts

Journal of Bone and Mineral Research

Volumn 30, Issue 7, 2015, Pages 1138-1149

  Ucer, Serra ^a   Iyer, Srividhya ^a   Bartell, Shoshana M ^a   Martin Millan, Marta ^a   Han, Li ^a   Kim, Ha Neui ^a   Weinstein, Robert S ^a   Jilka, Robert L ^a   O'Brien, Charles A ^a   Almeida, Maria ^a   Manolagas, Stavros C ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

genetic animal models; osteoblasts; osteoclasts; osteocytes; sex steroids

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; MESSENGER RNA; TESTOSTERONE; TRANSCRIPTION FACTOR OSTERIX; CRE RECOMBINASE; INTEGRASE;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; BONE MASS; CELL LINEAGE; CONTROLLED STUDY; CORTICAL BONE; FEMALE; GENE EXPRESSION; GENOTYPE; MALE; MOUSE; NONHUMAN; ORCHIECTOMY; OSTEOBLAST; OSTEOCLAST; OSTEOCLASTOGENESIS; PHENOTYPE; SIGNAL TRANSDUCTION; TRABECULAR BONE; ANIMAL; BONE; C57BL MOUSE; CYTOLOGY; DIAGNOSTIC IMAGING; DRUG EFFECTS; FEMUR; GENE DELETION; MESENCHYMAL STROMA CELL; METABOLISM; MICRO-COMPUTED TOMOGRAPHY; ORGAN SIZE;

ANDROGENS; ANIMALS; BONE AND BONES; CELL LINEAGE; ESTROGEN RECEPTOR ALPHA; FEMUR; GENE DELETION; INTEGRASES; MALE; MESENCHYMAL STROMAL CELLS; MICE, INBRED C57BL; ORCHIECTOMY; ORGAN SIZE; OSTEOBLASTS; OSTEOCLASTS; PHENOTYPE; RECEPTORS, ANDROGEN; SIGNAL TRANSDUCTION; X-RAY MICROTOMOGRAPHY;

EID: 84930186833     PISSN: 08840431     EISSN: 15234681     Source Type: Journal    
DOI: 10.1002/jbmr.2485     Document Type: Article

References (44)

1. Manolagas SC, O'Brien CA, Almeida M., The role of estrogen and androgen receptors in bone health and disease. Nat Rev Endocrinol. 2013; 9: 699-712.
2. Vanderschueren D, Laurent MR, Claessens F, et al., Sex steroid actions in male bone. Endocr Rev. 2014 Dec; 35 (6): 906-60.
3. Khosla S., Update on estrogens and the skeleton. J Clin Endocrinol Metab. 2010; 95: 3569-77.
4. Manolagas SC,. Birth and death of bone cells: Basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr Rev. 2000; 21: 115-37.
5. Jilka RL, Hangoc G, Girasole G, et al., Increased osteoclast development after estrogen loss: mediation by interleukin-6. Science 1992; 257: 88-91.
6. DiGregorio G, Yamamoto M, Ali A, et al., Attenuation of the self-renewal of transit amplifying osteoblast progenitors in the murine bone marrow by 17b-estradiol. J Clin Invest. 2001; 107: 803-12.
7. Manolagas SC,. From estrogen-centric to aging and oxidative stress: a revised perspective of the pathogenesis of osteoporosis. Endocr Rev. 2010; 31: 266-300.
8. Hughes DE, Dai A, Tiffee JC, Li HH, Mundy GR, Boyce BF,. Estrogen promotes apoptosis of murine osteoclasts mediated by TGF-b. Nat Med. 1996; 2: 1132-6.
9. Kousteni S, Bellido T, Plotkin LI, et al., Nongenotropic, sex-nonspecific signaling through the estrogen or androgen receptors: dissociation from transcriptional activity. Cell 2001; 104: 719-30.
10. Kousteni S, Chen J-R., Bellido T, et al., Reversal of bone loss in mice by nongenotropic signaling of sex steroids. Science 2002; 298: 843-6.
11. Tomkinson A, Reeve J, Shaw RW, Noble BS,. The death of osteocytes via apoptosis accompanies estrogen withdrawal in human bone. J Clin Endocrinol Metab. 1997; 82: 3128-35.
12. Kameda T, Mano H, Yuasa T, et al., Estrogen inhibits bone resorption by directly inducing apoptosis of the bone-resorbing osteoclasts. J Exp Med. 1997; 186: 489-95.
13. Kawano H, Sato T, Yamada T, et al., Suppressive function of androgen receptor in bone resorption. Proc Natl Acad Sci USA 2003; 100: 9416-21.
14. Callewaert F, Venken K, Ophoff J, et al., Differential regulation of bone and body composition in male mice with combined inactivation of androgen and estrogen receptor-alpha. FASEB. J. 2009; 23: 232-40.
15. Chiang C, Chiu M, Moore AJ, et al., Mineralization and bone resorption are regulated by the androgen receptor in male mice. J Bone Miner Res. 2009; 24: 621-31.
16. Notini AJ, McManus JF, Moore A, et al., Osteoblast deletion of exon 3 of the androgen receptor gene results in trabecular bone loss in adult male mice. J Bone Miner Res. 2007; 22: 347-56.
17. Sinnesael M, Claessens F, Laurent M, et al., Androgen receptor (AR) in osteocytes is important for the maintenance of male skeletal integrity: evidence from targeted AR disruption in mouse osteocytes. J Bone Miner Res. 2012; 27: 2535-43.
18. Maatta JA, Buki KG, Ivaska KK, et al., Inactivation of the androgen receptor in bone-forming cells leads to trabecular bone loss in adult female mice. Bonekey Rep. 2013; 2: 440.
19. De Gendt K, Swinnen JV, Saunders PT, et al., A Sertoli cell-selective knockout of the androgen receptor causes spermatogenic arrest in meiosis. Proc Natl Acad Sci USA 2004; 101: 1327-32.
20. Logan M, Martin JF, Nagy A, Lobe C, Olson EN, Tabin CJ,. Expression of Cre recombinase in the developing mouse limb bud driven by a Prxl enhancer. Genesis 2002; 33: 77-80.
21. Clausen BE, Burkhardt C, Reith W, Renkawitz R, Forster I, Conditional gene targeting in macrophages and granulocytes using LysMcre mice. Transgenic Res. 1999; 8: 265-77.
22. Martin-Millan M, Almeida M, Ambrogini E, et al., The estrogen receptor alpha in osteoclasts mediates the protective effects of estrogens on cancellous but not cortical bone. Mol Endocrinol. 2010; 24: 323-34.
23. Almeida M, Iyer S, Martin-Millan M, et al., Estrogen receptor-alpha signaling in osteoblast progenitors stimulates cortical bone accrual. J Clin Invest. 2013; 123: 394-404.
24. Davey RA, Clarke MV, Sastra S, et al., Decreased body weight in young Osterix-Cre transgenic mice results in delayed cortical bone expansion and accrual. Transgenic Res. 2011; 21: 885-93.
25. O'Brien CA, Jilka RL, Fu Q, Stewart S, Weinstein RS, Manolagas SC,. IL-6 is not required for parathyroid hormone stimulation of RANKL expression, osteoclast formation, and bone loss in mice. Am J Physiol Endocrinol Metab. 2005; 289: E784-93.
26. Bouxsein ML, Boyd SK, Christiansen BA, Guldberg RE, Jepsen KJ, Muller R., Guidelines for assessment of bone microstructure in rodents using micro-computed tomography. J Bone Miner Res. 2010; 25: 1468-86.
27. Almeida M, Han L, Bellido T, Manolagas SC, Kousteni S., Wnt proteins prevent apoptosis of both uncommitted osteoblast progenitors and differentiated osteoblasts by beta-catenin-dependent and -independent signaling cascades involving Src/ERK and phosphatidylinositol 3-kinase/AKT. J Biol Chem. 2005; 280: 41342-51.
28. Livak KJ, Schmittgen TD,. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001; 25: 402-8.
29. Altuwaijri S, Chuang KH, Lai KP, et al., Susceptibility to autoimmunity and B cell resistance to apoptosis in mice lacking androgen receptor in B cells. Mol Endocrinol. 2009; 23: 444-53.
30. Danilovic DL, Correa PH, Costa EM, Melo KF, Mendonca BB, Arnhold IJ,. Height and bone mineral density in androgen insensitivity syndrome with mutations in the androgen receptor gene. Osteoporos Int. 2007; 18: 369-74.
31. Vanderschueren D, Boonen S, Ederveen AG, et al., Skeletal effects of estrogen deficiency as induced by an aromatase inhibitor in an aged male rat model. Bone 2000; 27: 611-7.
32. Nakamura T, Imai Y, Matsumoto T, et al., Estrogen prevents bone loss via estrogen receptor alpha and induction of Fas ligand in osteoclasts. Cell 2007; 130: 811-23.
33. Windahl SH, Borjesson AE, Farman HH, et al., Estrogen receptor-alpha in osteocytes is important for trabecular bone formation in male mice. Proc Natl Acad Sci USA 2013; 110: 2294-9.
34. Maatta JA, Buki KG, Gu G, et al., Inactivation of estrogen receptor alpha in bone-forming cells induces bone loss in female mice. FASEB. J. 2013; 27: 478-88.
35. Melville KM, Kelly NH, Khan SA, et al., Female mice lacking estrogen receptor-alpha in osteoblasts have compromised bone mass and strength. J Bone Miner Res. 2014 Feb; 29 (2): 370-9.
36. Kondoh S, Inoue K, Igarashi K, et al., Estrogen receptor alpha in osteocytes regulates trabecular bone formation in female mice. Bone 2014; 60: 68-77.
37. Manolagas SC, Kronenberg HM,. Reproducibility of results in pre-clinical studies: a perspective from the bone field. J Bone Miner Res. 2014; 29: 2131-40.
38. Sakiani S, Olsen NJ, Kovacs WJ,. Gonadal steroids and humoral immunity. Nat Rev Endocrinol. 2013; 9: 56-62.
39. Onal M, Xiong J, Chen X, et al., Receptor activator of nuclear factor kappaB ligand (RANKL) protein expression by B lymphocytes contributes to ovariectomy-induced bone loss. J Biol Chem. 2012; 287: 29851-60.
40. Almeida M, Han L, Martin-Millan M, et al., Skeletal involution by age-associated oxidative stress and its acceleration by loss of sex steroids. J Biol Chem. 2007; 282: 27285-97.
41. Hughes IA, Davies JD, Bunch TI, Pasterski V, Mastroyannopoulou K, MacDougall J., Androgen insensitivity syndrome. Lancet 2012; 380: 1419-28.
42. Marcus R, Leary D, Schneider DL, Shane E, Favus M, Quigley CA,. The contribution of testosterone to skeletal development and maintenance: lessons from the androgen insensitivity syndrome. J Clin Endocrinol Metab. 2000; 85: 1032-7.
43. Rariy CM, Ratcliffe SJ, Weinstein R, et al., Higher serum free testosterone concentration in older women is associated with greater bone mineral density, lean body mass, and total fat mass: the cardiovascular health study. J Clin Endocrinol Metab. 2011; 96: 989-96.
44. Bertelloni S, Baroncelli GI, Sorrentino MC, Costa S, Battini R, S aggese G. Androgen-receptor blockade does not impair bone mineral density in adolescent females. Calcif Tissue Int. 1997;61:1-5.